ArticleHaematologica2024
Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.
Open access · goldAbstract readLetter
In one paragraph
Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 97% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 0 citations in OpenAlex.
- Addressing Obstetric and Gynecologic Needs in Thalassemia.O&G open · 2026Article
- Pubertal Assessment and Growth in Patients With Hemoglobinopathies: A Longitudinal Multicenter Study on the Association With Ferritin Levels.European journal of haematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors at 20 institutions in 1 country.
Mathilde Veneziano BrocciaService d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille, France; Centre de Reference MCGRE, Service d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille. Mathilde.veneziano-broccia@ap-hm.fr.
Julia VergierService de Pediatrie Multidisciplinaire, Hopital de la Timone Enfants, AP-HM, Marseille.
Audrey BenoitNational Thalassemia Registry (NaThalY), Service de Genetique, Hopital La Timone Enfants, APHM, Marseille.
Yoann HugueninService d'Oncologie et d'Hematologie Pediatrique, Hopital Pellegrin, CHU de Bordeaux, Bordeaux.
Anne LambilliotteService d'Hematologie et d'Oncologie Pediatrique, Centre Hospitalo-Universitaire de Lille, Lille.
Marie Pierre CastexService d'Hemato-Oncologie Pediatrique, Hopital des Enfants, Toulouse.
Stephanie GourdonService d'Oncologie et Hematologie Pediatrique, Centre Hospitalier Universitaire de La Reunion, Saint Denis.
Ghislaine IthierCentre de Reference MCGRE, Unite d'Hematologie, Hopital Robert Debre, Assistance Publique-Hopitaux de Paris (AP-HP), Paris.
Kamila KebailiInstitut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon.
Pierre RohrlichService d'Hematologie Pediatrique, CHU de Nice, Nice.
Corinne PondarreCentre de Reference MCGRE, Service de pediatrie, centre hospitalier intercommunal de Creteil, Creteil ; Inserm U955, Universite Paris-XII, Creteil.
Abdourahim ChamouineCentre de Reference MCGRE, Service de Pediatrie, Centre Hospitalier de Mayotte, Mamoudzou,Mayotte.
Pauline SimonService d'Hematologie Pediatrique, CHU de Besanc_on, Besanc_on.
Kokou Placide Agbo KpatiService de Pediatrie-Neonatologie-Medecine de l'Adolescent, GHEF-Site de Marne La Vallee, Jossigny.
Slimane AllaliCentre de Reference MCGRE, service de Pediatrie Generale, Hopital Necker-Enfants malades, AP-HP, Paris.
Sandrine Baron-JolyService de Pediatrie, CHU de Nimes, Nimes.
Sophie BayartService d'Hematologie Pediatrique, CHU de Rennes, Rennes.
Nicolas BillaudService de Pediatrie, CHR Metz-Thionville, Metz.
Valentine BrousseCentre de Référence MCGRE, Service d'Hematologie-Immunologie, Hopital Robert Debre, AP-HP, Paris.
Cecile DumesnilService d'Hematologie Pediatrique, CHU de Rouen, Rouen.
Nathalie GarnierInstitut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon.
Isabelle GuichardService de Medecine Interne, Hopital Nord, Saint-Etienne.
Laure JosephCentre de Reference MCGRE, CIC Biotherapie, Hopital Necker-Enfants malades, AP-HP, Paris France.
Annie KamdemCentre de Reference MCGRE, Service de Pediatrie, Centre Hospitalier Intercommunal de Creteil (CHIC), Creteil.
Julie MaitreService de Pediatrie, CHR d'Orleans, Orleans.
Catherine MatheyService d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille.
Catherine PaillardService d'Hematologie et d'Oncologie Pediatrique, Hopital Hautepierre, Strasbourg.
Aurelie PhulpinService d'Onco-hematologie Pediatrique, CHRU Nancy, Vandoeuvre les Nancy.
Cecile RenardInstitut d'Hematologie et d'Oncologie Pediatrique, Hospices Civils de Lyon, Lyon.
Cecile StovenService de Pediatrie, CHU La Reunion, Groupe Hospitalier Sud Reunion.
Mohamed TouatiService d'Hematologie Clinique, CHU Limoges, Limoges.
Capucine TrochuService de Pediatrie, Hopital d'Enfants, Roubaix.
Suzanne Mathieu NafissiHopitaux de Brabois, CHRU de Nancy, Vandoeuvre les Nancy.
Catherine BadensNational Thalassemia Registry (NaThalY), Service de Genetique, Hopital La Timone Enfants, APHM, Marseille.
Sarah SzepetowskiService d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille, France; Centre de Reference MCGRE, Service d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille.
Isabelle ThuretService d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille, France; Centre de Reference MCGRE, Service d'Hematologie, Immunologie et Oncologie Pediatrique, Hopital La Timone Enfants, AP-HM, Marseille.
Hôpital de la Timone · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Régional et Universitaire de Nancy · FRHôpital Robert-Debré · FRInstitut d’Hématologie et d’Oncologie Pédiatrique · FRCentre Hospitalier Régional de Metz-Thionville · FRCentre hospitalier régional d'Orléans · FRCentre Hospitalier Universitaire de La Réunion · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Limoges · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Nîmes · FRCentre Hospitalier Universitaire de Rennes · FRCentre Hospitalier Universitaire de Rouen · FRHôpital d'Enfants · FRHôpital des Enfants · FRHôpital d'Hautepierre · FRHôpital Intercommunal de Créteil · FRHôpital Nord · FRHôpital Pellegrin · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
DeferasiroxIron Chelating AgentsRegistriesThalassemiaAdministration, OralAdolescentBlood TransfusionChelation TherapyChildFemaleFranceHumansMalePubertyTriazolesDeferasiroxIron Chelating AgentsTriazoles
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.